Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Treatment sometimes absent for children of mothers with mental illness

Children who have a mother diagnosed with a mental illness are at risk of psychiatric and behavioral problems, yet these children often fail to receive needed services, a new University of Michigan study indicates.

2 Nov 2004

An errant enzyme linked to bipolar disorder impairs awareness, perception and reasoning

The disturbed thinking, impaired judgment, impulsivity, and distractibility seen in mania, a destructive phase of bipolar disorder, may be traceable to overactivity of protein kinase C (PKC), suggests the study, funded by the National Institute of Mental Health (NIMH) and National Institute on Aging (NIA), and the Stanley Foundation.

1 Nov 2004

Many patients with sleep apnea or insomnia also have attention deficit disorder

People who have difficulty sleeping at night or staying awake during the day may suffer from more than just a sleep disorder.

25 Oct 2004

Researchers are comparing two drugs used to treat pediatric bipolar disorder

University of Illinois at Chicago researchers are comparing two drugs used to treat pediatric bipolar disorder patients to evaluate how the drugs affect brain function in children with the disorder.

25 Oct 2004

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Researchers from the Johns Hopkins Children's Center say a group of drugs known as "atypical antipsychotics" that are commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance, a condition that increases the risk of developing Type 2 diabetes and heart disease later in life.

21 Oct 2004

Study shows how people with severe and persistent mental illnesses live their everyday lives

A study by two Indiana University Bloomington professors in the School of Health, Physical Education and Recreation is beginning to suggest how people with severe and persistent mental illnesses live their everyday lives.

13 Oct 2004

Lithium can protect the brain cells involved in learning and memory from radiation damage

Patients who undergo radiation for treatment of brain tumors may survive their cancer only to have lasting memory and learning deficiencies, the impact of which can be particularly devastating for children.

10 Oct 2004

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.

4 Oct 2004

New warnings on antidepressants for children and adolescents highlight the need for appropriate treatments for depression

“Taking an antidepressant comes with risks. When deciding whether an antidepressant is right for a son or daughter, parents should discuss with the physician the possible alternatives, including psychotherapy. Research by the National Institute of Mental Health shows that combining talk therapy and an antidepressant is the most effective treatment for teens battling depression,”

29 Sep 2004

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.

26 Sep 2004

Chiropractic correction may help reverse multiple sclerosis and Parkinson’s disease

A recent study of 81 cases, published in the Journal of Vertebral Subluxation Research (JVSR), is the first to show that correction of upper neck injuries may reverse the progression of both Multiple Sclerosis (MS) and Parkinson’s disease (PD).

10 Sep 2004

Approval of Cymbalta for treatment of major depressive disorder

The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.

5 Aug 2004

Framework for systematically incorporating epigenetic information into traditional genetic studies

Scientists at Johns Hopkins are calling for simultaneous evaluation of both genetic and epigenetic information in the search to understand contributors to such common diseases as cancer, heart disease and diabetes.

29 Jul 2004

Mollycoddled boys are more likely to grow into men who will be more successful at work and in their relationships

Boys who are “mollycoddled” as babies and toddlers are more likely to grow into men who will be more successful at work and in their relationships than babies who are taught to be tough.

10 Jul 2004

Texas Medication Algorithm Project guidelines produce improvements in patients with major depressive disorder

Results from a multiyear study of severely depressed patients treated according to guidelines established by researchers at UT Southwestern Medical Center at Dallas showed a significant improvement in patients' symptoms and medical outcomes.

5 Jul 2004

People who suffer from severe depression have more nerve cells in the part of the brain that controls emotion

Studies of postmortem brains of patients diagnosed with major depressive disorder (MDD) showed a 31 percent greater than average number of nerve cells in the portion of the thalamus involved with emotional regulation.

2 Jul 2004

First university-based research center devoted to studying epigenetics

With a $5 million, five-year federal grant, The Johns Hopkins University School of Medicine is establishing what is believed to be the first university-based research center devoted to studying epigenetics

28 Jun 2004

Common illnesses are associated with an increased risk of suicide in elderly people

Many common illnesses are independently associated with an increased risk of suicide in elderly people, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Jun 2004

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e. bipolar disorder.

3 Jun 2004

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Imagine suffering frequent, extreme and disabling mood swings that won’t go away despite years of different treatments and diagnoses.

26 May 2004

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Treatment sometimes absent for children of mothers with mental illness

An errant enzyme linked to bipolar disorder impairs awareness, perception and reasoning

Many patients with sleep apnea or insomnia also have attention deficit disorder

Researchers are comparing two drugs used to treat pediatric bipolar disorder

Atypical antipsychotics commonly used to treat children with aggression, bipolar disorder, and schizophrenia may trigger insulin resistance

Study shows how people with severe and persistent mental illnesses live their everyday lives

Lithium can protect the brain cells involved in learning and memory from radiation damage

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

New warnings on antidepressants for children and adolescents highlight the need for appropriate treatments for depression

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

Chiropractic correction may help reverse multiple sclerosis and Parkinson’s disease

Approval of Cymbalta for treatment of major depressive disorder

Framework for systematically incorporating epigenetic information into traditional genetic studies

Mollycoddled boys are more likely to grow into men who will be more successful at work and in their relationships

Texas Medication Algorithm Project guidelines produce improvements in patients with major depressive disorder

People who suffer from severe depression have more nerve cells in the part of the brain that controls emotion

First university-based research center devoted to studying epigenetics

Common illnesses are associated with an increased risk of suicide in elderly people

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Newsletters you may be interested in